Q-omics provides the consensus-scored LINC01952 profile across patient tissues and cancer cell-line models. LINC01952 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC01952 is differentially expressed in 9, with the highest sampling consensus in COAD. Additionally, LINC01952 RNA expression shows 13,364 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight ACC, COAD, and THYM as cancer lineages where LINC01952 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01952 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01952 survival associations across molecular data types. LINC01952 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01952 RNA expression–survival associations across cancer types. High LINC01952 expression shows unfavorable associations in ACC, KIRC and LGG, but favorable associations in LUSC, THCA and PAAD. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC01952 RNA expression.
This table summarizes LINC01952 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01952. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01952 shows lower tumor expression in KIRC, THCA and KICH and higher tumor expression in COAD, LIHC and BLCA. The COAD box plot shows higher LINC01952 RNA expression in tumor versus normal tissue (log2 FC = +0.225, t-test p < 0.001).
This table shows molecular features associated with LINC01952 in patient tissues and cancer cell lines. In patient samples, LINC01952 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
